Metraipolis › archive › dc_fd20b7bb6c0d
Understanding the early molecular changes associated with radiation therapy-A preliminary bulk RNA sequencing study — Europe PMC PMID:40029831
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40029831
- DOI
- 10.1371/journal.pone.0316443
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-06T13:17:55.728Z
- SHA-256 of the archived text
5a3e86bc9f78d256b5e02b207bd5e48b7c169db37a0d4da11c97fc54a6cbd23e- Stable URL of this page
https://metraipolis.com/documento/dc_fd20b7bb6c0d
How to cite
Understanding the early molecular changes associated with radiation therapy-A preliminary bulk RNA sequencing study — Europe PMC PMID:40029831 — Europe PMC (en), https://europepmc.org/article/MED/40029831 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_fd20b7bb6c0d (Metraipolis archive dc_fd20b7bb6c0d, sha256 5a3e86bc9f78d256b5e02b207bd5e48b7c169db37a0d4da11c97fc54a6cbd23e)
BibTeX
@misc{dcfd20b7bb6c0d,
title = {Understanding the early molecular changes associated with radiation therapy-A preliminary bulk RNA sequencing study — Europe PMC PMID:40029831},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40029831},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_fd20b7bb6c0d; sha256 5a3e86bc9f78d256b5e02b207bd5e48b7c169db37a0d4da11c97fc54a6cbd23e},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/40029831. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Introduction: Cancer is the second leading cause of death in the United States, with breast cancer being the most commonly diagnosed new cancer in women. Radiation therapy provides well-documented survival and recurrence benefits; however, it can lead to significant adverse effects, such as radiation-induced fibrosis (RIF), which can cause pain and result in poor aesthetic outcomes. The biological mechanisms underlying RIF are not entirely understood and require further investigation to identify potential intervention avenues. In this study, we investigated the biological response to radiation therapy by analyzing non-irradiated and irradiated tissues from breast cancer patients. Materials and methods: We collected tissue from breast cancer patients who underwent unilateral radiation and bilateral breast reconstruction. At the time of final reconstruction (post-radiation), samples were collected from both non-irradiated and irradiated reconstruction sites. These samples were analyzed using bulk RNA sequencing, histology, and immunohistochemistry (IHC). Results: In fibrous tissue capsules, CLCA2, COL4A5, and COL6A6 were differentially expressed and may be related to reduced micro-vascularization. CXCL9 and PTCHD4 were upregulated within the skin, possibly conferring an increased immune response, while multiple keratin-related genes (KRT6B, KRT17, KRT25, KRT28, and KRT75) were downregulated. In irradiated muscle tissue, there was increased expression of CXCL10 and downregulation of DCD. These results were confirmed using IHC. Conclusions: This study highlights the utility of bulk RNA sequencing studies in conjunction with IHC to identify target genes and biological processes responsible for RIF in tissues at final breast reconstruction. Due to the sample size limitation, further research is warranted to understand the role of keratin and collagen genes in regulating epidermal changes, vascularity, and fibrosis. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PloS one, 2025 (prima pubblicazione 2025-03-03). Identificativi: PMID 40029831 · PMCID PMC11875373 · DOI 10.1371/journal.pone.0316443. Descrittori MeSH principali: Breast Neoplasms; Radiation Injuries. Pagina: https://europepmc.org/article/MED/40029831 — https://doi.org/10.1371/journal.pone.0316443. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-10-06T11:32:36.102Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.